Aurinia Pharmaceuticals (AUPH) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist

8.860
+0.010+0.11%

Close Nov 29 13:00 ET

8.900
+0.040+0.45%

Post 17:01 ET

1.27BMarket Cap-59066P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified
Simply Wall StNov 23 07:31 ET
Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness
Simply Wall StNov 22 05:44 ET
Positive Outlook for Aurinia Pharmaceuticals Boosted by Favorable Lupus Nephritis Guidelines
TipRanksNov 21 01:17 ET
Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)
TipRanksNov 19 20:40 ET · Ratings
Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
BusinesswireNov 18 17:53 ET
Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis
ReutersNov 18 17:53 ET

Comments

frogoracletrading

Nov 7 12:07

$AUPH Support / Resistance Levels

Here are the levels to keep an eye on. After breaking over 8.50 watch for a retest of that level.
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$

frogoracletrading

Oct 29 14:41

$AUPH Support / Resistance Levels

Into the GAP now. Here are the levels to watch into AH.
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$

Jaguar8

Oct 11 06:03

NEWS

$Aurinia Pharmaceuticals (AUPH.US)$
Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts at the American Society of Nephrology (ASN) Kidney Week 2024. The data reinforces the clinical importance of LUPKYNIS® (voclosporin) for treating adults with active lupus nephritis (LN). Key highlights include:
...